Bank of America Defends Palantir’s Valuation Amid Ethical Controversies

Palantir remains a polarizing figure in both tech and finance circles. While its data analytics software draws scrutiny over privacy and surveillance concerns, Wall Street's focus remains squarely on its financial metrics. The stock's forward price-to-sales ratio approaches 100 against projected revenue—a premium that WOULD give most software investors pause.

Bank of America analyst Mariana Perez Mora, ranked in the top 2% of Wall Street experts, counters valuation concerns with a blunt assessment: "If it works, it's not expensive." She highlights Palantir's forward deployed engineers (FDEs) as the company's secret weapon, particularly in deploying AI solutions for enterprise clients. These specialized teams work directly with customers to customize platforms and solve operational challenges—a service Mora describes as an "accelerator of growth."

The debate encapsulates modern market dichotomies: ethical considerations versus growth potential, lofty valuations versus execution capability. As AI adoption grows, Palantir's government contracts and corporate deployments may test whether premium multiples reflect fundamental value or speculative excess.